Pfizer to acquire cancer drugmaker Seagen

By Becker's Hospital Review - Healthcare News in Becker's Hospital Review, Channels, Featured, ROOT
February 27, 2023

Pfizer said March 13 it will acquire Seagen, a cancer therapeutics company, for $43 billion.

Read the full post on Becker's Hospital Review - Healthcare News

Becker's Hospital Review - Healthcare News